Speaker Profile
PhD, Vice President of Clinical and Scientific Affairs, Bionano
Biography
Dr. Alex Hastie has committed the last 12 years of his career to bringing a novel technique, optical genome mapping (OGM), into everyday use as a key tool for understanding the genome. Alex works closely with the clinical genomics community, to help them demonstrate the value of OGM for the sensitive assessment of structural variants in germ line and somatic genomes and their role in disease and treatment opportunities. These highly rewarding relationships have resulted in dozens of publications on optical genome mapping in genomics, human research, clinical research, and cell and gene therapy.
Talk
Revolutionizing Cytogenetics Through Optical Genome Mapping
Cytogenetics has remained the standard practice for clinical genetic testing. This is because of the early realization that structural variants are a hallmark disease. Optical genome mapping is a technique that is revolutionizing cytogenomics and unlocking the understanding of structural variants in the genome at a level never seen before.
Genomic Profiling Showcase:
Bionano
Bionano is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company’s mission is to transform the way the world sees the genome through OGM solutions, diagnostic services and software.
Session Abstract – PMWC 2024 Silicon Valley
The PMWC 2024 Genomic Profiling Showcase will provide a 15 min speaking opportunity for selected companies working with the latest technologies in nucleic acid sequencing such as NGS, providing instrumentation for genomic sequencing, and offering direct to consumer services. These companies will share their innovative products and services to an audience of leading investors, potential clients and partners. The Genomic Profiling Showcase will exhibit the latest innovations in methods and instruments used for DNA/ RNA sequencing to ascertain the genomic and transcriptional profile of a person in order to understand why some people get certain diseases while others do not, or why people react in different ways to the same drug. This information is also being used to develop new ways to diagnose, treat, and prevent diseases, such as cancer.
